Before selecting a provider, compare pricing, availability, and whether virtual consultations are available
(2008) demonstrated that systemic administration of IGF-1 LR3 to dystrophic mdx mice (a model of Duchenne muscular dystrophy) significantly reduced susceptibility to contraction-mediated damage in extensor digitorum longus, soleus, and diaphragm muscles
Long-Term GLP-1 Use: Efficacy and Safety Considerations Extended GLP-1 use beyond two years remains safe in most patients, with side effect profiles remaining stable over time
However, the impact of RAAS and OS on LC symptoms and CV manifestations needs further evaluation
It plays a central role in: Boosting insulin and reducing glucagon, which helps stabilise blood sugar Slowing gastric emptying , so food stays in your stomach longer Promoting satiety , the feeling of being full and satisfied This is why GLP-1 is a major focus in both obesity and type 2 diabetes care, and why medications that mimic it have become so widely used

Common indications include: Pernicious anaemia an autoimmune condition where the stomach cannot produce intrinsic factor, a protein necessary for B12 absorption [8] [9] Malabsorption disorders including Crohn's disease, coeliac disease, or following gastric surgery Strict vegan or vegetarian diets with confirmed deficiency though high-dose oral B12 may be sufficient if no malabsorption exists Certain medications such as metformin or proton pump inhibitors that may interfere with B12 absorption [9] [10] Neurological symptoms including peripheral neuropathy, memory problems, or balance difficulties related to deficiency Diagnosis should be confirmed through blood tests measuring serum B12 levels, full blood count, folate, and often anti-intrinsic factor antibodies